Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,084
Closed -$781K 4684
2025
Q4
$781K Sell
3,084
-975
-24% -$245K ﹤0.01% 1868
2025
Q3
$1M Sell
4,059
-16,685
-80% -$3.99M ﹤0.01% 1517
2025
Q2
$4.98M Buy
20,744
+14,382
+226% +$3.35M 0.02% 538
2025
Q1
$1.44M Buy
6,362
+4,573
+256% +$1.01M 0.01% 956
2024
Q4
$367K Buy
+1,789
New +$392K ﹤0.01% 1606
2022
Q1
Sell
-1,877
Closed -$456K 3825
2021
Q4
$456K Buy
+1,877
New +$429K ﹤0.01% 1963
2020
Q3
Sell
-10,719
Closed -$1.64M 2319
2020
Q2
$1.64M Buy
10,719
+5,347
+100% +$814K 0.05% 392
2020
Q1
$751K Sell
5,372
-120,185
-96% -$18M 0.05% 310
2019
Q4
$19.1M Buy
+125,557
New +$18.4M 0.82% 17
2019
Q2
Sell
-2,217
Closed -$283K 902
2019
Q1
$283K Buy
+2,217
New +$261K 0.04% 307

Other funds holding STE

HRT Financial's STE Position: Q1 2026 in Review

HRT Financial sold out of Steris (STE) in Q1 2026, closing a stake of 3,084 shares — an estimated $781K sold.

HRT Financial first reported a position in STE in Q1 2019 and held it in 10 quarters. The position peaked at $19.1M in Q4 2019. 838 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • HRT Financial reported no remaining Steris position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 3,084 Steris shares in Q1 2026, an estimated $781K.
  • HRT Financial first reported a position in Steris in Q1 2019 and held it in 10 quarters.
  • HRT Financial's Steris position peaked at $19.1M in Q4 2019.
  • 838 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.